The Xtrackers MSCI EAFE High Dividend Yield Equity ETF seeks to track the MSCI EAFE High Dividend Yield Index, a benchmark derived from the broader MSCI EAFE Index that selects developed-market stocks outside the U.S. and Canada with higher dividend income and quality characteristics that are both sustainable and persistent. The fund is cap-weighted, non-diversified, and typically holds around 140 to 150 securities.
Top holdings include SHEL (Shell), Roche, Novartis, Nestlé, Allianz, TTE (TotalEnergies), Iberdrola, UL (Unilever), DBS Group, and NVO (Novo Nordisk). Sector exposure is concentrated in financial services (about 27%), consumer staples (about 19%), healthcare (about 16%), energy (about 12%), utilities (about 8%), and industrials (about 7%), with minimal technology weight. Geographically, the portfolio is dominated by the United Kingdom, Switzerland, France, and Germany, with smaller allocations to Japan, Singapore, Spain, and Australia. I also checked this using Tickeron’s AI Screener to see how the holdings compare to peers in the industry.
Structurally, this portfolio exposure tilts the fund toward defensive, dividend-paying value companies rather than high-growth technology names. That positioning tends to make the ETF more rate-sensitive and currency-sensitive than broad international indexes, while offering a steadier income profile during periods of economic uncertainty.
The macro backdrop is likely to remain a defining force for this ETF's future trajectory. If major developed-market central banks continue normalizing or gradually lowering rates, the financial services sector could see pressure on net interest margins, although lower funding costs and resilient credit conditions may offset some of that drag. Conversely, a higher-for-longer rate environment tends to support bank earnings but increases competition from fixed income for yield-seeking investors. From what I see, the defensive tilt in staples and healthcare helps buffer volatility, though growth still hinges on input costs, currency effects, and regulatory developments in healthcare.
Consumer staples and healthcare provide defensive ballast, but their growth outlook depends on input costs, currency translation, and, for healthcare, innovation and regulatory policy. The energy allocation links the fund to global supply-demand balances and the pace of the energy transition. With almost no technology exposure, the ETF is less levered to artificial intelligence-driven equity rallies, but its value tilt and lower valuation multiples offer a distinct risk profile relative to growth-heavy international benchmarks. A weaker dollar would generally enhance unhedged foreign-currency returns, while a stronger dollar acts as a headwind.
Over the long term, several structural themes support the asset class this ETF represents. Aging demographics across Europe and Japan sustain demand for healthcare products and services, while a broad investor preference for income-generating strategies could keep capital flowing toward high-dividend international equities. The fund's quality-and-dividend screening favors mature companies with established cash flows, a profile that can appeal in slower-growth or late-cycle economic environments.
Interest rate cycles will remain pivotal: a gradual easing cycle could reduce fixed-income competition and support dividend-oriented equities, while persistent inflation might favor the fund's energy and financials exposure. The global energy transition is a longer-running variable that could reshape the energy names in the portfolio over time. Although the fund's minimal technology weight limits participation in rapid innovation cycles, its lower-valuation, defensive composition positions it as a potential stabilizer within a globally diversified portfolio, subject to currency and regional economic risks.
In my own work, I often turn to Tickeron's Trend Prediction Engine when evaluating potential direction for ETFs like this one. It offers a practical way to assess bullish, bearish, or sideways trends over the coming weeks or months, adding a data-driven layer to the fundamental and macro review without replacing core analysis.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The Moving Average Convergence Divergence (MACD) for HDEF turned positive on October 12, 2026. Looking at past instances where HDEF's MACD turned positive, the stock continued to rise in 37 of 43 cases over the following month. The odds of a continued upward trend are 86%.
The Momentum Indicator moved above the 0 level on October 13, 2026. You may want to consider a long position or call options on HDEF as a result. In 58 of 71 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
HDEF moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for HDEF crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 72%.
Following a +0.76% 3-day Advance, the price is estimated to grow further. Considering data from situations where HDEF advanced for three days, in 262 of 318 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Aroon Indicator entered an Uptrend today. In 280 of 354 cases where HDEF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.
The 10-day RSI Indicator for HDEF moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 46 similar instances where the indicator moved out of overbought territory. In 29 of the 46 cases, the stock moved lower in the following days. This puts the odds of a move lower at 63%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 44 of 60 cases where HDEF's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 73%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HDEF declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
HDEF broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category ForeignLargeValue